Gavin W. G. Wilkinson

10.4k citations

101 papers · 8.0k indexed · 1 hit paper · h-index 52

Parasitology top 0.2%
- Toxoplasma gondii Research Studies 15
Epidemiology top 0.2%
- Cytomegalovirus and herpesvirus research 61
- Herpesvirus Infections and Treatments 32
Immunology top 0.5%
- Immune Cell Function and Interaction 27
- T-cell and B-cell Immunology 13
Virology top 1%
Genetics top 2%
- Virus-based gene therapy research 28
Molecular Biology
- Viral Infectious Diseases and Gene Expression in Insects 7
- RNA Interference and Gene Delivery 6

Co-authors: Brian P. McSharry Peter Tomašec Richard J. Stanton A. Akrigg Andrew J. Davison Eddie C. Y. Wang Carole Rickards Leszek K. Borysiewicz
Cited by: Parasitology Epidemiology Immunology
Journals: Science (2 papers)Cell (1 paper)Proceedings of the National Academy of Sciences (7 papers)
Partner nations: United Kingdom United States Czechia

In The Last Decade

Gavin W. G. Wilkinson

100 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Gavin W. G. Wilkinson

Since Specialization

Citations

This map shows the geographic impact of Gavin W. G. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin W. G. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin W. G. Wilkinson more than expected).

Fields of papers citing papers by Gavin W. G. Wilkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin W. G. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin W. G. Wilkinson. The network helps show where Gavin W. G. Wilkinson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gavin W. G. Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin W. G. Wilkinson Line = papers co-authored together Gavin W. G. Wilkinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation Proceedings of the National Academy of Sciences ·Virginia-Maria Vlachava,Sepehr Seirafian,Ceri A. Fielding,Simon Kollnberger,Rebecca Aicheler,Joseph Hughes,Alexander T. Baker,Michael P. Weekes,Simone K. Forbes,Gavin W. G. Wilkinson,Eddie C. Y. Wang,Richard J. Stanton	2023	7
2	Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus Journal of Clinical Investigation ·Virginia-Maria Vlahava,Isa Murrell,Lihui Zhuang,Rebecca Aicheler,Eleanor Y. Lim,Kelly L. Miners,Kristin Ladell,Nicolás M. Suárez,David A. Price,Andrew J. Davison,Gavin W. G. Wilkinson,Mark R. Wills,Michael P. Weekes,Eddie C. Y. Wang,Richard J. Stanton	2021	26
3	Downregulation of HLA-I by the molluscum contagiosum virus mc080 impacts NK-cell recognition and promotes CD8+ T-cell evasion Journal of General Virology ·Hana A Elasifer,Eddie C. Y. Wang,Virginie Prod’homme,James A. Davies,Simone K. Forbes,Richard J. Stanton,Mihil Patel,Ceri A. Fielding,Dawn Roberts,James A. Traherne,Nicole Gruber,Joachim J. Bugert,Rebecca Aicheler,Gavin W. G. Wilkinson	2020	5
4	Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation eLife ·Ceri A. Fielding,Michael P. Weekes,Luís Nobre,Eva Růčková,Gavin S. Wilkie,João A. Paulo,Chiwen Chang,Nicolás M. Suárez,James A. Davies,Robin Antrobus,Richard J. Stanton,Rebecca Aicheler,Hester Nichols,Bořivoj Vojtěšek,John Trowsdale,Andrew J. Davison,Steven P. Gygi,Peter Tomašec,Paul J. Lehner,Gavin W. G. Wilkinson	2017	56
5	Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo Virus Genes ·Nicolás M. Suárez,Betty Lau,George Kemble,Ronzo Lee,Edward S. Mocarski,Gavin W. G. Wilkinson,Stuart P. Adler,Michael A. McVoy,Andrew J. Davison	2017	10
6	Human cytomegalovirus: taking the strain Medical Microbiology and Immunology ·Gavin W. G. Wilkinson,Andrew J. Davison,Peter Tomašec,Ceri A. Fielding,Rebecca Aicheler,Isa Murrell,Sepher Seirafian,Eddie C. Y. Wang,Michael P. Weekes,Paul J. Lehner,Gavin S. Wilkie,Richard J. Stanton	2015	113
7	CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue PLoS Pathogens ·Gabrielle Stack,Emma Jones,Morgan Marsden,Maria A. Stacey,Robert J. Snelgrove,Paul Lacaze,Laura C. Jacques,Simone Cuff,Richard J. Stanton,Awen Gallimore,Tracy Hussell,Gavin W. G. Wilkinson,Peter Ghazal,Philip R. Taylor,Ian R. Humphreys	2015	13
8	Neutrophils Recruited by IL-22 in Peripheral Tissues Function as TRAIL-Dependent Antiviral Effectors against MCMV Cell Host & Microbe ·Maria A. Stacey,Morgan Marsden,Tu Anh Pham N.,Simon Clare,Garry Dolton,Gabrielle Stack,Emma Jones,Paul Klenerman,Awen Gallimore,Philip R. Taylor,Robert J. Snelgrove,Trevor D. Lawley,Gordon Dougan,Chris A. Benedict,Simon A. Jones,Gavin W. G. Wilkinson,Ian R. Humphreys	2014	57
9	HCMV pUL135 Remodels the Actin Cytoskeleton to Impair Immune Recognition of Infected Cells Cell Host & Microbe ·Richard J. Stanton,Virginie Prod’homme,Marco A. Purbhoo,Melanie Moore,Rebecca Aicheler,Marcus Heinzmann,Susanne M. Bailer,Jürgen Haas,Robin Antrobus,Michael P. Weekes,Paul J. Lehner,Bořivoj Vojtěšek,Kelly L. Miners,Stephen Man,Gavin S. Wilkie,Andrew J. Davison,Eddie C. Y. Wang,Peter Tomašec,Gavin W. G. Wilkinson	2014	61
10	The TNF-Like Protein 1A–Death Receptor 3 Pathway Promotes Macrophage Foam Cell Formation In Vitro The Journal of Immunology ·James E. McLaren,Claudia J. Calder,Brian P. McSharry,Keith Sexton,Rebecca C. Salter,Nishi N. Singh,Gavin W. G. Wilkinson,Eddie C. Y. Wang,Dipak P. Ramji	2010	68
11	Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection Virology ·Claire Mattick,D Dewin,Smarajit Polley,Edgar Sevilla-Reyes,Sara Pignatelli,William D. Rawlinson,Gavin W. G. Wilkinson,Paola Dal Monte,Ursula A. Gompels	2004	55
12	An Outbreak of Epidemic Keratoconjunctivitis Caused by Adenovirus Type 37 Journal of Medical Microbiology ·Sally Curtis,Gavin W. G. Wilkinson,D. Westmoreland	1998	11
13	Therapeutic Vaccines for Cervical Cancer BioDrugs ·Alison Fiander,Stephen Man,Leszek K. Borysiewicz,Gavin W. G. Wilkinson	1997	3
14	Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. Journal of General Virology ·A.F. Shering,K Stewart,María G. Castro,Derek Bain,Pedro R. Löwenstein,Alberto L. Epstein,Gavin W. G. Wilkinson	1997	64
15	Immunization of Mice with Plasmid DNA Expressing the Measles Virus Nucleoprotein Gene Viral Immunology ·Anthony R. Fooks,D. JEEVARAJAH,Alan Warnes,Gavin W. G. Wilkinson,J. C. S. Clegg	1996	24
16	A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer The Lancet ·Leszek K. Borysiewicz,Alison Fiander,M. Nimako,Stephen Man,Gavin W. G. Wilkinson,D. Westmoreland,A. S. Evans,Malcolm Adams,Simon Stacey,M. E. G. Boursnell,Erica Rutherford,Julian Hickling,Stephen Inglis	1996	426
17	High-Level Expression of the Measles Virus Nucleocapsid Protein by Using a Replication-Deficient Adenovirus Vector: Induction of an MHC-1-Restricted CTL Response and Protection in a Murine Model Virology ·Anthony R. Fooks,Eva B. Schadeck,Uwe G. Liebert,A. B. Dowsett,B. K. Rima,Michael Steward,John Stephenson,Gavin W. G. Wilkinson	1995	62
18	Gene therapy and viral vaccination: the interface British Medical Bulletin ·Gavin W. G. Wilkinson,Leszek K. Borysiewicz	1995	12
19	Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1 Journal of General Virology ·S. Jacobs,J Stephenson,Gavin W. G. Wilkinson	1994	44
20	Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures Journal of General Virology ·Anthony R. Fooks,John Stephenson,Alan Warnes,A. B. Dowsett,B. K. Rima,Gavin W. G. Wilkinson	1993	82

About Gavin W. G. Wilkinson

Gavin W. G. Wilkinson is a scholar working on Parasitology, Epidemiology and Immunology, having authored 101 papers that have together received 8.0k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (61 papers), Herpesvirus Infections and Treatments (32 papers), Virus-based gene therapy research (28 papers), Immune Cell Function and Interaction (27 papers), Toxoplasma gondii Research Studies (15 papers), T-cell and B-cell Immunology (13 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Parasitology (1.2k citations), Epidemiology (5.6k citations) and Immunology (3.2k citations). Gavin W. G. Wilkinson has collaborated with scholars based in United Kingdom, United States and Czechia. Frequent co-authors include Brian P. McSharry, Peter Tomašec, Richard J. Stanton, A. Akrigg, Andrew J. Davison, Eddie C. Y. Wang, Carole Rickards, Leszek K. Borysiewicz, Charles Cunningham and Paul J. Lehner. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact